The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...

Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Has a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...

The ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...

India Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...

A commerce ministry official said a couple of Indian drug makers have also agreed, in principle, to set up manufacturing facilities in Hida...

Earlier, around 3,000 pharma companies had their manufacturing units in Maharashtra.

Even off patent drugs which are in the market for long and commonly used for diseases like HIV, tuberculosis and malaria are priced very hi...

Months after the Modi regime took over in May 2014, the Planning Commission was recast and it was left to the new avatar —Niti Aayog — to l...

A Glenmark spokesperson said Indian pharma companies are known to offer products at lesser prices and it will look to address the rising dr...

The experts would look into the impact of foreign direct investment in the brownfield pharmaceutical companies and access to affordable med...

Generic drugs form the largest segment, with 75 per cent of market share (in terms of revenues), of the Indian pharmaceutical sector.

Union Minister Ananth Kumar said cost of the centres would be around Rs 100 crore and these would provide generic medicines at a very low c...

The Supreme Court’s landmark judgment on the Novartis Glivec case — disallowing a patent on minor modifications — has started a global deba...

India tops in the world in exporting generic medicines worth of Rs 50,000 crore and currently, the Indian pharmaceutical industry is one of...